Understanding how patient and visit characteristics affect knee osteoarthritis outcomes
Official title: The Effects of Patient and Visit Characteristics on Health Outcomes in Knee Osteoarthritis
Run by University of California, Davis · NCT06574191 · Data updated 2026-11-12
This study is testing how different factors about patients and their clinic visits can affect how well older adults with knee osteoarthritis respond to treatment with a topical gel.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 50 Years and up |
| Sex | All |
| Enrollment | 220 (estimated) |
| Sponsor | University of California, Davis Academic / other |
| Locations | 1 site (Sacramento, California) |
| Status | Recruiting |
| Started | January 29, 2025 |
| Main results expected | January 27, 2028 |
| Study ends | January 27, 2028 |
| Registry record updated | March 30, 2026 |
| Trial ID | NCT06574191 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are English-speaking adults aged 50 and older with radiographically confirmed knee osteoarthritis and significant knee pain.
✕Probably not a fit
Patients with medical contraindications to NSAIDs, inflammatory arthritis, or recent knee surgeries may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to explore the relationship between patient and clinic visit characteristics and health outcomes in individuals suffering from knee osteoarthritis (OA) pain treated with topical diclofenac gel. It will involve 220 older adults who will attend two study visits, complete questionnaires, and apply the gel for eight weeks. The study will assess baseline patient characteristics, physiological responses during visits, and other visit characteristics to predict responses to treatment. Participants will also report their pain and gel usage biweekly via text messages to track changes over time.
Why it matters
Potential benefit: If successful, this study could help identify which patient characteristics lead to better outcomes with topical diclofenac, potentially improving treatment strategies for knee osteoarthritis.
How similar studies have gone: Other studies have shown success in understanding treatment responses in knee osteoarthritis, but this specific approach focusing on patient and visit characteristics is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * English-speaking * 50 years of age or older * Radiographically confirmed knee OA of K/L grade 2 or higher within the past 2 years * Knee pain at least 15 days/month. * Average worst daily pain 3/10 or higher over a two-week period. Exclusion Criteria: * Medical contraindication to taking NSAIDs such as: history of coronary artery bypass graft, myocardial infarction, coronary artery stent placement, or stroke within the past 6 months; systolic heart failure with ejection fraction \<45%; chronic kidney disease stage ≥4; severe gastrointestinal bleed or stomach ulcer within the past 6 months; current pregnancy; cirrhosis; currently taking blood thinners (aspirin 81 mg daily is okay); allergy to NSAIDs or aspirin; or any other medical contraindication to using topical NSAIDs. * Inflammatory arthritis * Partial or total knee replacement of the index knee * Recent therapeutic injection of the index knee (less than 12 weeks) * Planned knee/lower limb surgery during the two-month study period * Active cancer treatment not in remission or life expectancy less than 6 months * Inability to provide informed consent (e.g. dementia) * Current use of topical or oral NSAIDs more than 3 days per week. * Inability to receive text messages or emails to complete questionnaires between study visits. * Unable to follow the study protocol.
Where it's running
-
University of California Davis Health
Sacramento, California, United States Recruiting
Study contacts
- Principal investigator: Michelle Dossett, MD, PhD — University of California, Davis
- Study coordinator: Maya Porter
- Email: mtporter@ucdavis.edu
- Phone: 916-734-4216
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effects of virtual reality on walking in adults with knee osteoarthritis
This study tests how immersive virtual reality environments—designed to feel safe or to provoke fear—affect walking and worry about movement in adults 50 and older with knee osteoarthritis and in healthy peers.
-
Weekly berobenatide for knee osteoarthritis in adults who are overweight or obese
This study tests whether weekly berobenatide helps reduce knee pain and improve function, while also affecting body weight, in adults with knee osteoarthritis who are overweight or obese (with or without type 2 diabetes).
-
Autologous adipose-derived stem cell injections for knee osteoarthritis
We’re testing whether injecting a patient’s own fat-derived stem cells into the knee can help people with knee OA feel less pain and move better, compared with a standard hyaluronic acid treatment.
-
Preoperative Multimorbidity and Functional Recovery After Total Knee Arthroplasty
This study tests whether higher burden of preoperative multimorbidity affects functional recovery after knee replacement in adults with knee osteoarthritis.
-
Cartilage biomarker response to acute loading in knee OA by antiresorptive treatment status
Researchers will test whether a 30-minute treadmill walk changes cartilage biomarkers in postmenopausal women with knee osteoarthritis, comparing those on denosumab, bisphosphonates, and those not on antiresorptives.
-
Lysyl Enzymes in Knee Osteoarthritis
This study tests whether blood levels of lysyl hydroxylase and lysyl oxidase differ between people with knee osteoarthritis and healthy individuals.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.